BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 26385)

  • 1. Molecular studies of subspecificity differences among phosphorylcholine-binding mouse myeloma antibodies using 31P nuclear magnetic resonance.
    Goetze AM; Richards JH
    Biochemistry; 1978 May; 17(9):1733-9. PubMed ID: 26385
    [No Abstract]   [Full Text] [Related]  

  • 2. Structure-function relations in phosphorylcholine-binding mouse myeloma proteins.
    Goetze AM; Richards JH
    Proc Natl Acad Sci U S A; 1977 May; 74(5):2109-12. PubMed ID: 405672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Magnetic resonance studies of the binding site interactions between phosphorylcholine and specific mouse myeloma immunoglobulin.
    Goetze AM; Richards JH
    Biochemistry; 1977 Jan; 16(2):228-32. PubMed ID: 556944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The binding of analogs of phosphorylcholine by the murine myeloma proteins McPC 603, MOPC 167 and S107.
    Young NM; Leon MA
    Immunochemistry; 1977; 14(11-12):757-61. PubMed ID: 598858
    [No Abstract]   [Full Text] [Related]  

  • 5. Modulations of glycerophosphorylcholine and phosphorylcholine in Friend erythroleukemia cells upon in vitro-induced erythroid differentiation: a 31P NMR study.
    Carpinelli G; Podo F; Di Vito M; Proietti E; Gessani S; Belardelli F
    FEBS Lett; 1984 Oct; 176(1):88-92. PubMed ID: 6593228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A combined proton and phosphorus-31 nuclear magnetic resonance investigation of the combining site of M603, a phosphocholine-binding myeloma protein.
    Gettins P; Pótter M; Leatherbarrow RJ; Dwek RA
    Biochemistry; 1982 Sep; 21(20):4927-31. PubMed ID: 6291593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fine specificity of rabbit anti-p-azophenylphosphorylcholine antibodies; comparison with HOPC-8 myeloma protein.
    Krausz LM; Grossberg AL; Pressman D
    Immunochemistry; 1976 Nov; 13(11):901-5. PubMed ID: 1010599
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of haptens on the reaction of anti-idiotype antibody with a mouse anti-phosphorylcholine plasmacytoma protein.
    Sher A; Cohn M
    J Immunol; 1972 Jul; 109(1):176-8. PubMed ID: 5035242
    [No Abstract]   [Full Text] [Related]  

  • 9. Immune response to phosphorylcholine. I. Characterization of the epitope-specific antibody.
    Kluskens L; Lee W; Köhler H
    Eur J Immunol; 1976 Jul; 5(7):489-96. PubMed ID: 61872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction of saccharide haptens with myeloma proteins. A 270-MHz proton nuclear magnetic resonance study.
    Gettins P; Boyd J; Glaudemans CP; Potter M; Dwek RA
    Biochemistry; 1981 Dec; 20(26):7463-9. PubMed ID: 6275881
    [No Abstract]   [Full Text] [Related]  

  • 11. Incorporation of a phosphonium analogue of choline into the rat brain as measured by magnetic resonance spectroscopy.
    Jiménez JV; Richards TL; Heide AC; Grierson JR; Shankland EG
    Magn Reson Med; 1995 Mar; 33(3):285-92. PubMed ID: 7760696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new neuronal marker identified by phosphorylcholine-binding myeloma proteins.
    Hooghe-Peters EL; Fowlkes BJ; Hooghe RJ
    Nature; 1979 Oct; 281(5730):376-8. PubMed ID: 481600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Magnetic resonance studies of the binding site interactions between 19F-labeled nitrophenyl haptens and specific mouse myeloma immunoglobulin MOPC-315.
    Kooistra DA; Richards JH
    Biochemistry; 1978 Jan; 17(2):345-51. PubMed ID: 619995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Crystals of phosphorylcholine-binding Fab-fragments from mouse myeloma proteins: preparation and x-ray analysis.
    Rudikoff S; Potter M; Segal DM; Padlan EA; Davies DR
    Proc Natl Acad Sci U S A; 1972 Dec; 69(12):3689-92. PubMed ID: 4566456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigation of hapten-antibody interactions in McPC603 by 1 H and 31 P NMR spectroscopy.
    Gettins P; Potter M; Rudikoff S; Dwek RA
    FEBS Lett; 1977 Dec; 84(1):87-91. PubMed ID: 590531
    [No Abstract]   [Full Text] [Related]  

  • 16. Relation between structure and specificity of antibodies: nuclear magnetic resonance study of binding fluorine-19 labeled nitrophenyl haptens to myeloma immunoglobulins M315, M460, and X25.
    Hardy RR; Richards JH
    Biochemistry; 1978 Sep; 17(18):3866-71. PubMed ID: 698204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure of a phosphorycholine-binding mouse myeloma Fab.
    Padlan EA; Segal DM; Cohen GH; Davies DR; Rudikoff S; Potter M
    Transplant Proc; 1975 Jun; 7(2):219-22. PubMed ID: 48300
    [No Abstract]   [Full Text] [Related]  

  • 18. Structural, functional, and idiotypic characteristics of a phosphorylcholine-binding IgA myeloma protein of C57BL/ka allotype.
    Claflin JL; Rudikoff S; Potter M; Davie JM
    J Exp Med; 1975 Mar; 141(3):608-19. PubMed ID: 46916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clonal nature of the immune response to phosphorylcholine (PC). V. Cross-idiotypic specificity among heavy chains of murine anti-PC antibodies and PC-binding myeloma proteins.
    Claflin JL; Davie JM
    J Exp Med; 1975 May; 141(5):1073-83. PubMed ID: 47894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. kappa Chain variable region from M167, a phosphorylcholine binding myeloma protein.
    Rudikoff S; Potter M
    Biochemistry; 1978 Jul; 17(14):2703-7. PubMed ID: 99160
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.